Rudy Ligtvoet

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Diffuse Large B Cell Lymphoma

Ejection Fraction

Top Venues

Nature medicine

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Florian Simon, Rudy Ligtvoet, Sandra Robrecht, Paula Cramer, Nadine Kutsch, Moritz Fürstenau, Valentin Goede, Julia von Tresckow, Petra Langerbeins, Anna-Maria Fink, Henriette Huber, Eugen Tausch, Christof Schneider, Clemens M Wendtner, Matthias Ritgen, Martin Dreyling, Lothar Müller, Lutz Jacobasch, Werner J Heinz, Ursula Vehling-Kaiser, Liliya Sivcheva, Sebastian Böttcher, Peter Dreger, Thomas Illmer, Michael Gregor, Philipp Bernhard Staber, Stephan Stilgenbauer, Carsten Utoft Niemann, Arnon P Kater, Kirsten Fischer, Barbara Eichhorst, Michael Hallek, Othman Al-Sawaf
Endpoint Surrogacy in First-Line Chronic Lymphocytic Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Othman Al-Sawaf, Rudy Ligtvoet, Sandra Robrecht, Janina Stumpf, Anna-Maria Fink, Eugen Tausch, Christof Schneider, Sebastian Boettcher, Martin Mikusko, Matthias Ritgen, Johannes Schetelig, Julia von Tresckow, Ursula Vehling-Kaiser, Tobias Gaska, Clemens Martin Wendtner, Bjoern Chapuy, Kirsten Fischer, Karl-Anton Kreuzer, Stephan Stilgenbauer, Philipp Bernhard Staber, Carsten Utoft Niemann, Michael Hallek, Barbara Eichhorst
Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial. Nature medicine (2023)
Rudy Ligtvoet
Incomplete Tests of Conditional Association for the Assessment of Model Assumptions. Psychometrika 87 (4) (2022)